Bioceres Crop Solutions Acquires Stake in Moolec Science and Enters Fast Growing Alternative Food Market
16 Mars 2021 - 2:23PM
Business Wire
New Initiative Positions Bioceres With Emerging
Developers of Food Technologies for Alternative Proteins and
Oils
6% Stake in Exchange for GLA Safflower Oil
Intellectual Property Rights Acquired in November 2020
GLA IP Complements Moolec’s Existing
Technologies, Improving Competitiveness of Safflower Molecular
Farming Platform
Bioceres Crop Solutions Corp.
(“Bioceres”) (NYSE American: BIOX), a fully-integrated global
provider of crop productivity solutions designed to enable the
transition of agriculture towards carbon neutrality, has entered
into definitive agreements for the acquisition of a 6% ownership
interest in Moolec Science Ltd. (“Moolec”), a Molecular Farming
company pursuing a hybrid concept between plant and cell-based
technologies for the production of animal-free food solutions.
Moolec is developing products based on multiple crops to obtain
functionalized alternative protein concentrates and isolates.
Through genetic engineering, the company aims to produce
animal-free solutions at a much lower cost than that offered by
existing technologies, by using the scalability of plant-based
production systems to leverage the functionality attained through
cellular agriculture.
Moolec has developed and fully de-regulated the world’s first
bovine protein derived from modified safflower grain, a patented
technology branded under the SPC name. Through a joint venture
subsidiary, Moolec operates a dedicated industrial facility for the
production of protein concentrates and oils. Using “plants as
bioreactors,” Moolec has set its sights on developing other animal
proteins and improved oils from crops such as soybeans, peas,
wheat, and oat, which can then be formulated into sustainable
hybrid meat, dairy, and egg replacements.
According to a recent report, worldwide alternative proteins
market valuation reached USD $14.95 billion in 2019 and is expected
to grow considerably over 2020-2025. Rising demand for plant-based
food products is driving the industry growth due to increasing
health, environmental -mainly GHG emissions- and animal welfare
consciousness among consumers.
Mr. Federico Trucco, Chief Executive Officer of Bioceres, said:
“We are excited to partner with Moolec, a company that we have
known since inception and one with which we share a common origin.
This transaction allows Bioceres to gain exposure to a fast-growing
industry that is aligned with our purpose of helping food systems
transition to carbon neutrality. GLA assets are non-core to our
business focus at Bioceres and this transaction will unlock greater
potential value from this asset in the hands of a company
specifically dedicated to the alternative food space like Moolec,”
concluded Trucco.
About Moolec Science Ltd.
Moolec Science is an Ag-Foodtech company that consolidates a
unique pipeline of projects and capabilities with more than one
decade under development. It introduces a hybrid concept that
includes the cost structure of plant-based solutions with the
organoleptic properties and functionality of cell-based platforms.
With a proof of concept for the cheese market, the team is known
for being the first to produce a functional protein (bovine
chymosin) in plants (safflower) through Molecular Farming. A family
of international patent applications currently covers this
platform, with events fully de-regulated for cost-effective
large-scale production. Currently, the company is consolidating
different research lines to produce unique blends of highly
functional and nutritional animal proteins in protein-rich crops
(soybean, peas, wheat, and oat) and create a new generation of
meat, dairy, and egg replacements. Moolec is run by a diverse team
with operations in the United States, Europe, and South America,
and its purpose is to improve the affordability of animal-free
solutions in favor of true sustainability. For more information,
click here.
About Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp. (NYSE American: BIOX) is a fully
integrated global provider of crop productivity technologies
designed to enable the transition of agriculture towards carbon
neutrality. To do this, Bioceres’ solutions create economic
incentives for farmers and other stakeholders to adopt
environmentally friendlier production practices. The Company has a
unique biotech platform with high-impact, patented technologies for
seeds and microbial ag-inputs, as well as next generation crop
nutrition and protection solutions. Through its HB4® program, the
Company is bringing digital solutions to support growers’ decisions
and provide end-to-end traceability for production outputs. For
more information, click here.
Forward-Looking Statements
This communication includes “forward-looking statements” within
the meaning of the “safe harbor” provisions of the United States
Private Securities Litigation Reform Act of 1995. Forward-looking
statements may be identified by the use of words such as
“forecast,” “intend,” “seek,” “target,” “anticipate,” “believe,”
“expect,” “estimate,” “plan,” “outlook,” and “project” and other
similar expressions that predict or indicate future events or
trends or that are not statements of historical matters. Such
forward-looking statements are based on management’s reasonable
current assumptions, expectations, plans and forecasts regarding
the Company’s current or future results and future business and
economic conditions more generally. Such forward-looking statements
involve risks, uncertainties and other factors, which may cause the
actual results, levels of activity, performance or achievement of
the Company to be materially different from any future results
expressed or implied by such forward-looking statements, and there
can be no assurance that actual results will not differ materially
from management’s expectations or could affect the Company’s
ability to achieve its strategic goals, including the uncertainties
relating to the impact of COVID-19 on the Company’s business,
operations, liquidity and financial results and the other factors
that are described in the sections entitled “Risk Factors” in the
Company's Securities and Exchange Commission filings updated from
time to time. The preceding list is not intended to be an
exhaustive list of all of our forward-looking statements.
Therefore, you should not rely on any of these forward-looking
statements as predictions of future events. All forward-looking
statements contained in this release are qualified in their
entirety by this cautionary statement. Forward-looking statements
speak only as of the date they are or were made, and the Company
does not intend to update or otherwise revise the forward-looking
statements to reflect events or circumstances after the date of
this release or to reflect the occurrence of unanticipated events,
except as required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210316005679/en/
Investor Relations Contact: Chris Tyson, Executive Vice
President MZ Group – MZ North America (949) 491-8235
BIOX@mzgroup.us www.mzgroup.us
Bioceres Crop Solutions Máximo Goya, Head of Investor
Relations +54-341-4861100 maximo.goya@biocerescrops.com
Moolec Science Catalina Jones, Communications Manager
catalina@moolecscience.com
Bioceres Crop Solutions (AMEX:BIOX)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Bioceres Crop Solutions (AMEX:BIOX)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024